155 related articles for article (PubMed ID: 8944778)
1. The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids.
Gallois L; Fiallo M; Laigle A; Priebe W; Garnier-Suillerot A
Eur J Biochem; 1996 Nov; 241(3):879-87. PubMed ID: 8944778
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study.
Gallois L; Fiallo M; Garnier-Suillerot A
Biochim Biophys Acta; 1998 Mar; 1370(1):31-40. PubMed ID: 9518541
[TBL] [Abstract][Full Text] [Related]
3. Permeability of lipid bilayer to anthracycline derivatives. Role of the bilayer composition and of the temperature.
Frézard F; Garnier-Suillerot A
Biochim Biophys Acta; 1998 Jan; 1389(1):13-22. PubMed ID: 9443599
[TBL] [Abstract][Full Text] [Related]
4. Orientation of anthracyclines in lipid monolayers and planar asymmetrical bilayers: a surface-enhanced resonance Raman scattering study.
Heywang C; Saint-Pierre Chazalet M; Masson CM; Bolard J
Biophys J; 1998 Nov; 75(5):2368-81. PubMed ID: 9788932
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine.
Frézard F; Pereira-Maia E; Quidu P; Priebe W; Garnier-Suillerot A
Eur J Biochem; 2001 Mar; 268(6):1561-7. PubMed ID: 11248673
[TBL] [Abstract][Full Text] [Related]
6. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
Mankhetkorn S; Garnier-Suillerot A
Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
[TBL] [Abstract][Full Text] [Related]
7. DNA-containing liposomes as a model for the study of cell membrane permeation by anthracycline derivatives.
Frezard F; Garnier-Suillerot A
Biochemistry; 1991 May; 30(20):5038-43. PubMed ID: 2036371
[TBL] [Abstract][Full Text] [Related]
8. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
Mankhetkorn S; Dubru F; Hesschenbrouck J; Fiallo M; Garnier-Suillerot A
Mol Pharmacol; 1996 Mar; 49(3):532-9. PubMed ID: 8643093
[TBL] [Abstract][Full Text] [Related]
9. Selectivity of the anthracyclines for negatively charged model membranes: role of the amino group.
Burke TG; Sartorelli AC; Tritton TR
Cancer Chemother Pharmacol; 1988; 21(4):274-80. PubMed ID: 3370735
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
[TBL] [Abstract][Full Text] [Related]
11. pH dependence of daunorubicin interactions with model DMPC:Cholesterol membranes.
Matyszewska D; Brzezińska K; Juhaniewicz J; Bilewicz R
Colloids Surf B Biointerfaces; 2015 Oct; 134():295-303. PubMed ID: 26209780
[TBL] [Abstract][Full Text] [Related]
12. Modulation of lysozyme charge influences interaction with phospholipid vesicles.
Zschörnig O; Paasche G; Thieme C; Korb N; Arnold K
Colloids Surf B Biointerfaces; 2005 Apr; 42(1):69-78. PubMed ID: 15784328
[TBL] [Abstract][Full Text] [Related]
13. Daunorubicin and doxorubicin molecular interplay with 2D membrane models.
Alves AC; Nunes C; Lima J; Reis S
Colloids Surf B Biointerfaces; 2017 Dec; 160():610-618. PubMed ID: 29028609
[TBL] [Abstract][Full Text] [Related]
14. Anthracycline subcellular distribution in human leukemic cells by microspectrofluorometry: factors contributing to drug-induced cell death and reversal of multidrug resistance.
Morjani H; Millot JM; Belhoussine R; Sebille S; Manfait M
Leukemia; 1997 Jul; 11(7):1170-9. PubMed ID: 9205008
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance modulator interactions with neutral and anionic liposomes: membrane binding affinity and membrane perturbing activity.
Castaing M; Loiseau A; Mulliert G
J Pharm Pharmacol; 2005 May; 57(5):547-54. PubMed ID: 15901343
[TBL] [Abstract][Full Text] [Related]
16. The daunorubicin interplay with mimetic model membranes of cancer cells: A biophysical interpretation.
Alves AC; Ribeiro D; Horta M; Lima JL; Nunes C; Reis S
Biochim Biophys Acta Biomembr; 2017 May; 1859(5):941-948. PubMed ID: 28153496
[TBL] [Abstract][Full Text] [Related]
17. The role of charge and hydrophobicity in peptide-lipid interaction: a comparative study based on tryptophan fluorescence measurements combined with the use of aqueous and hydrophobic quenchers.
De Kroon AI; Soekarjo MW; De Gier J; De Kruijff B
Biochemistry; 1990 Sep; 29(36):8229-40. PubMed ID: 2252886
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells.
Frezard F; Garnier-Suillerot A
Eur J Biochem; 1991 Mar; 196(2):483-91. PubMed ID: 1672520
[TBL] [Abstract][Full Text] [Related]
19. Location and dynamics of anthracyclines bound to unilamellar phosphatidylcholine vesicles.
Burke TG; Tritton TR
Biochemistry; 1985 Oct; 24(21):5972-80. PubMed ID: 3866609
[TBL] [Abstract][Full Text] [Related]
20. High-affinity small molecule-phospholipid complex formation: binding of siramesine to phosphatidic acid.
Parry MJ; Alakoskela JM; Khandelia H; Kumar SA; Jäättelä M; Mahalka AK; Kinnunen PK
J Am Chem Soc; 2008 Oct; 130(39):12953-60. PubMed ID: 18767848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
